All of these factors can be controlled with the use of excipients and formulation science
Dose Control
Why formulate to control dose?
Dose
Aspirin tablet typically has 300mg API
Ethinyl estradiol - 0.035mg (1/8000 of the dose of aspirin)
Difficult to manufacture - blend uniformly for low dose drugs
Dose
High dose (low potency) drugs can be a problem to formulate if they have poor flow/compressibility
Taste
Very subjective and difficult to quantify. Many drugs are extremely bitter. Can be mitigated by film-coating.
Panadol formulation
Paracetamol (API)
Starch (disintegrant)
Povidone (PVP) (diluent/disintegrant)
Potassium sorbate (E202) (sweetener)
Talc (flow agent)
Stearic acid (lubricant)
Film coating contains hydroxypropyl methylcellulose (HPMC) and triacetin
Panadol Actifast Formulation
Paracetamol (Active ingredient)
Sodium bicarbonate (super-disintegrant)
Soluble starch (disintegrant)
Povidone (PVP) (diluent/disintegrant)
Potassium sorbate (E 202) (Sweetener)
Microcrystalline cellulose (filler)
Magnesium stearate (lubricant)
Carnauba wax (coating)
Titanium dioxide (E 171) (Whitening agent)
Film coating contains polydextrose, hypromellose (HPMC), glycerol triacetate and polyethylene glycol
Sodium bicarbonate
Can increase the rate of tablet disintegration and dissolution as well as the rate of gastric emptying. Enables a faster speed of absorption of paracetamol to provide faster onset of relief.
If one tablet or if taken with less than 100mL water, the rate of absorption of paracetamol for PanadolActiFast is the same as for standardparacetamol tablets.
Excipient
All the other components of a formulation other than the active drug
Excipients
Each component requires an appropriateevaluation for safety
An excipient should be chemically and physiologically inert
People may have moral or religious problems with excipients e.g. gelatin
Uses for excipients
Aid processing of the system during manufacture
Protect, support or enhance stability, bioavailability or acceptability
Assist in product identification
Enhance any other attribute of the overall safety and effectiveness of the drug product during storage and use
Rates of drug dissolution can be adversely affected by choice of formulation additives
Tableting lubricants are particularly troublesome. Insoluble magnesium stearate imparts hydrophobicity to a formulation which inhibits drug dissolution.
Need to minimise the % of lubricant in a solid dosage formulation. If possible!
Diluents (bulking agents)
Inert substances which are added to the active ingredient to make a reasonable sized tablet
Tablet Diluents
Dicalcium Phosphate- inexpensive, insoluble in water
α-Lactose monohydrate- inexpensive, relatively inert, compressibility related to crystalline/amorphous form
Mannitol- Freely soluble, chewable tablets
Microcrystalline cellulose- excellent compression properties, has some disintegration properties
Sodium chloride- freely soluble, used for solution tablets
Sucrose- sweet taste but hygroscopic
Starch- very hygroscopic, good disintegration properties
Microcrystalline Cellulose
Outstanding compressibility and high tablet strength from low compression forces
Has some lubricant & disintegrating properties
Sensitive to lubricant – lubricant hinders strong bonds forming between layers (weakens tablet)
Moisture sensitive (5% moisture uptake)
MCC- Various Grades
Particle Size (90 µm, 200 µm, 15 µm)
Low moisture grade (1.5%) – reduced compression
Higher bulk density – aids in blending
Low bulk density – increase tablet strength
Lubricants
Necessary to prevent adherence of the formulation to punches and dies
They also ensure smooth ejection of the tablet from the die
Some act as anti-adherents and flow aids
Lubricants
Talc
Magnesium stearate
Stearic acid
Magnesium Stearate
Most popular lubricant in tabletting
Incorporated with dry granules prior to compression
A thin layer of magnesium stearate around the granules is as effective a lubricant as a thick layer (concentration up to 1% w/w)
Self-lubricating properties
Increased concentration of magnesium stearate decreases disintegration time, drug dissolution and weakens the bonding forces (soft tablets), reduction due to its hydrophobic nature.
Magnesium stearate is incompatible with many drugs (e.g. Aspirin requires talc or stearic acid)
Flow agents/Glidants
Materials which are added to tablet formulations in order to improve the flow properties of granules
They act by reducing inter-particle friction
Flow agents
Fumed silica, a synthetic amorphous colloidal silicon dioxide (Aerosil or Cab-O-Sil)
Action of flow agents
The reduction in contact area between granules reduces the interparticle cohesion/adhesion, which determines flowability
Disintegrants
Promote break up of tablets in vivo
First stage in the dissolution process of a drug
Important primarily in the dissolution of insoluble drugs, particularly those with a high dose
Its role is to rapidly disintegrate a tablet to increase the surface area of the formed disaggregates, promoting rapid release of drug
Mechanisms of disintegrant action
Swelling
Porosity and capillary action
Deformation
Gas production
Most common disintegrant is starch. Others include polyvinylpyrrolidone (PVP), modified starches and cellulose materials.
Super disintegrants
Modified starch (Sodium starch glycolate) has rapid and extensive swelling with minimal gelling
More effective in lower concentrations (4 – 6%)
Reduces issues relating to the compressibility and flowability problems of starch
However, it is more hygroscopic
Binding agents (adhesives)
Bind powders together in the wet granulation process or granules during direct compression
Can affect dissolution rate
Binding agents
Starch mucilage
Gelatin
Polyvinylpyrrolidone (PVP)
Adsorbents
Substances which are capable of holding quantities of fluids in an apparently dry state
Liquid flavourings, fluid extracts or oils can be mixed with adsorbents and granulated and compressed into tablets